Meiyu Li

2.0k citations
43 papers · 1.3k indexed · 1 hit paper · h-index 19
Topics
COVID-19 diagnosis using AI (7 papers)Advanced Neural Network Applications (6 papers)MicroRNA in disease regulation (5 papers)
Partner nations
ChinaUnited StatesCanada

In The Last Decade

Meiyu Li

42 papers receiving 1.3k citations

Hit Papers

Mitochondrial dysfunction in aging2023202620242025202350100150

Peers

Meiyu Li
Comparison fields: 5 of 116
  • Molecular Biology 523
  • Immunology 294
  • Cancer Research 287
  • Epidemiology 256
  • Infectious Diseases 167
Replace Sameet Mehta with:
Sameet Mehta United States
Hang‐Rae Kim South Korea
René Deenen Germany
Kelli L. VanDussen United States
Hwa‐Young Youn South Korea
Brijendra K Tiwari India
Alessandra Piersigilli United States
Sina Bartfeld Germany
Qun Gao China
Zhenyu Zhao China
Meiyu Li relative to Sameet Mehta United States Sameet Mehta's profile →
Citations per field
00.5×1.5×
Sameet Mehta · 1×
Citations per year

Countries citing papers authored by Meiyu Li

Since Specialization
Citations

This map shows the geographic impact of Meiyu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiyu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiyu Li more than expected).

Fields of papers citing papers by Meiyu Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meiyu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiyu Li. The network helps show where Meiyu Li may publish in the future.

Co-authorship network of co-authors of Meiyu Li

This figure shows the co-authorship network connecting the top 25 collaborators of Meiyu Li. A scholar is included among the top collaborators of Meiyu Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meiyu Li. Meiyu Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 5
3 5
4 13
5 12
6 47
7 7
8 18
9 8
10 3
11 1
12 13
13 39
14 4
15 37
16 70
17 32
18 208
19 8
20 3

About Meiyu Li

Meiyu Li is a scholar working on Developmental Neuroscience, Immunology and Computer Vision and Pattern Recognition, having authored 43 papers that have together received 1.3k indexed citations. Recurring topics across this work include COVID-19 diagnosis using AI (7 papers), Advanced Neural Network Applications (6 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Cancer Research (287 citations), Immunology (294 citations) and Parasitology (78 citations). Meiyu Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Xi Huang, Minhao Wu, Yongjian Wu, Kun Yang, Jinli Wang, Min Zhu, Qiuchan Deng, Ying Guo, Qiang Yu and Jiming Kong. Their work appears in journals such as Proceedings of the National Academy of Sciences, Scientific Reports and ACS Applied Materials & Interfaces.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026